Archives for January 22, 2009

← 2009

Valois targets compliance with equadel add-ons

By Nick Taylor

Valois Pharma has informed in-PharmaTechnologist that it is developing a range of add-ons for its equadel nasal drug delivery device, which the company believes will help improve patient compliance.

CEE could gain from Asia’s reputation for fakes

By Gareth Macdonald

A new report suggests the large numbers of fake drugs produced in China could drive CMO customers away and see Central and Eastern Europe (CEE) emerge as a contract manufacturing hotbed.

Preterm babies could face toxic excipient levels

By Phil Taylor

Preterm infants are routinely exposed to pharmaceutical excipients at levels which could potentially be toxic, according to researchers at Leicester Royal Infirmary in the UK.

Consolidation in CRO sector as Premier buys Pivotal

By Phil Taylor

UK-headquartered Premier Research Group has signed a deal to buy the assets of fellow contract research organisation (CRO) Pivotal Research Centers, a specialist in Phase I to IIa trials, for $4.75m.

Clinical research meets Facebook

By Phil Taylor

A social networking tool specifically designed for patients involved in clinical trials has been set up by Acurian, a company specialising in patient recruitment services.